Related Experiment Video

Updated: Jul 9, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

CD30 supports lung inflammation

Sang-Yun Nam1, Young-Hyun Kim, Jeong-Su Do

  • 1Department of Biological Science, School of Science and Technology, Jeonju University, Jeonju 560-759, Korea.

International Immunology
|December 20, 2007
PubMed

Insights

CD30 deficiency reduces lung inflammation and eosinophil recruitment in a mouse model of airway hyperreactivity. This is linked to decreased Interleukin-13 (IL-13) production, highlighting CD30's role in T(h)2 responses.

Area of Science:

  • Immunology
  • Respiratory Medicine

Background:

  • The precise physiological roles of CD30 remain incompletely understood.
  • CD30 is a receptor expressed on activated lymphocytes, implicated in immune regulation.

Purpose of the Study:

  • To investigate the function of CD30 in the context of allergic airway inflammation and airway hyperreactivity.
  • To determine the impact of CD30 deficiency on immune cell recruitment and cytokine production in the lung.

Main Methods:

  • Utilized a mouse model of ovalbumin (OVA)-induced airway hyperreactivity.
  • Compared CD30-deficient (CD30(-/-)) mice with wild-type (w.t.) littermates.
  • Assessed immune cell populations (especially eosinophils) and cytokine levels (IL-13, IFN-gamma, IL-4, IL-5) in bronchoalveolar lavage fluid, lung tissue, and serum.
  • Performed in vitro re-stimulation of lymph node cells and adoptive cell transfers.

Main Results:

  • CD30(-/-) mice exhibited significantly diminished lung inflammation and eosinophil recruitment following OVA challenge compared to w.t. mice.
  • Interleukin-13 (IL-13) levels were significantly reduced in CD30(-/-) mice, while other cytokines (IFN-gamma, IL-4, IL-5) and IgE levels remained comparable.
  • In vitro studies showed reduced IL-13 secretion from CD30(-/-) cells, with normal proliferation and other cytokine production.
  • Administration of exogenous IL-13 restored leukocyte recruitment in OVA-challenged CD30(-/-) mice.
  • Adoptive transfer of OVA-primed spleen cells from CD30(-/-) mice failed to induce eosinophilic inflammation in naive w.t. recipients.

Conclusions:

  • CD30 acts as a crucial regulator of T(h)2 responses during the effector-memory phase of allergic airway inflammation.
  • CD30 plays a significant role in regulating IL-13 production by memory cells within the lung.
  • Targeting CD30 may offer therapeutic potential for managing allergic lung diseases characterized by IL-13-driven inflammation.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...